Related Experiment Video
Updated: Jul 16, 2026

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
Published on: February 5, 2019
Pediatric palliative care in Canada in 2012: a cross-sectional descriptive study
Kimberley Widger1, Dawn Davies1, Adam Rapoport1
1Lawrence S. Bloomberg Faculty of Nursing (Widger), University of Toronto; The Hospital for Sick Children (Widger, Rapoport), Toronto, Ont.; John Dossetor Health Ethics Centre (Davies), University of Alberta; Stollery Children's Hospital (Davies), Edmonton, Alta.; Departments of Paediatrics and of Family & Community Medicine (Rapoport), University of Toronto, Toronto, Ont.; Children's Hospital of Eastern Ontario (Vadeboncoeur), Ottawa, Ont.; Montreal Children's Hospital, McGill University Health Centre (Liben), Montréal, Que.; Children's Hospital London Health Sciences Centre (Sarpal), London, Ont.; Winnipeg Regional Health Authority (Stenekes), Winnipeg, Man.; Centre hospitalier universitaire de Sherbrooke (Cyr), Sherbrooke, Que.; Centre hospitalier universitaire Sainte-Justine (Daoust), Montréal, Que.; IWK Health Centre (Grégoire), Halifax, NS; University of Calgary (Robertson); Rotary/Flames House (Robertson), Calgary, Alta.; University of Saskatchewan; Royal University Hospital (Hodgson-Viden), Saskatoon, Sask.; Centre hospitalier universitaire de Québec (Laflamme), Québec, Que.; Child & Family Research Institute (Siden); Canuck Place Children's Hospice (Siden), Vancouver, BC.
Background:
Pediatric palliative care focuses on comprehensive symptom management and enhancing quality of life for children with life-threatening conditions and their families. Our aim was to describe Canadian programs that provided specialized pediatric palliative care in 2012 and the children who received it and to estimate the proportion of children who might benefit that received specialized care.
Methods:
A cross-sectional descriptive design was used. Specialized pediatric palliative care programs were included in the study if they offered multidisciplinary consulting pediatric palliative care services to a wide range of children and served all populations of children with life-threatening illness regardless of diagnosis. Investigators in programs that had taken part in a prior study were invited to participate. New programs that met the inclusion criteria were identified through snowball sampling within pediatric palliative care networks. Program data were obtained via surveys with coinvestigators, and health record reviews were used to obtain information about the children who received care through the programs.
Results:
All 13 programs identified, including 3 with a free-standing hospice, agreed to take part in the study. Of the 1401 children who received care, 508 (36.2%) were under 1 year of age, and 504 (36.0%) had a congenital illness or condition originating in the perinatal period. Of the 431 children who died in 2012, 105 (24.4%) died in a critical care setting. Programs with a hospice provided care to 517 children (36.9%). Children in this group tended to be older, more often had a neurologic illness and received care for a longer time than those who received care from programs without a hospice. Overall, 18.6% (95% confidence interval 17.1%-20.3%) of deceased children who might have benefitted from specialized pediatric palliative care based on diagnosis received such care, with 110 (25.2%) receiving care for less than 8 days.
Interpretation:
Program growth and changes in patients' demographic and clinical characteristics indicate improved reach of programs. However, barriers remain that prevent most children with life-threatening conditions from receiving specialized pediatric palliative care services.
Related Concept Videos
Continuing Care
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
